E-mail this article

Sending your article

Your article has been sent.

Genzyme Corp. , which is locked in merger talks with French drug maker Sanofi-Aventis SA, is not the first major Massachusetts biotechnology company to be pursued by a major pharmaceutical company. And it likely will not be the last.(Full article: 889 words)